BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24067434)

  • 1. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.
    Medjeral-Thomas N; Malik TH; Patel MP; Toth T; Cook HT; Tomson C; Pickering MC
    Kidney Int; 2014 Apr; 85(4):933-7. PubMed ID: 24067434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
    Togarsimalemath SK; Sethi SK; Duggal R; Le Quintrec M; Jha P; Daniel R; Gonnet F; Bansal S; Roumenina LT; Fremeaux-Bacchi V; Kher V; Dragon-Durey MA
    Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl.
    Besbas N; Gulhan B; Gucer S; Korkmaz E; Ozaltin F
    J Nephrol; 2014 Aug; 27(4):457-60. PubMed ID: 24536001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHR-5 Serum Levels and
    Garam N; Cserhalmi M; Prohászka Z; Szilágyi Á; Veszeli N; Szabó E; Uzonyi B; Iliás A; Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G; Bajcsi D; Brunner J; Dumfarth A; Cejka D; Flaschberger S; Flögelova H; Haris Á; Hartmann Á; Heilos A; Mueller T; Rusai K; Arbeiter K; Hofer J; Jakab D; Sinkó M; Szigeti E; Bereczki C; Janko V; Kelen K; Reusz GS; Szabó AJ; Klenk N; Kóbor K; Kojc N; Knechtelsdorfer M; Laganovic M; Lungu AC; Meglic A; Rus R; Kersnik Levart T; Macioniene E; Miglinas M; Pawłowska A; Stompór T; Podracka L; Rudnicki M; Mayer G; Rysava R; Reiterova J; Saraga M; Seeman T; Zieg J; Sládková E; Stajic N; Szabó T; Capitanescu A; Stancu S; Tisljar M; Galesic K; Tislér A; Vainumäe I; Windpessl M; Zaoral T; Zlatanova G; Józsi M; Csuka D
    Front Immunol; 2021; 12():720183. PubMed ID: 34566977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.
    Athanasiou Y; Voskarides K; Gale DP; Damianou L; Patsias C; Zavros M; Maxwell PH; Cook HT; Demosthenous P; Hadjisavvas A; Kyriacou K; Zouvani I; Pierides A; Deltas C
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1436-46. PubMed ID: 21566112
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zipfel PF; Wiech T; Stea ED; Skerka C
    J Am Soc Nephrol; 2020 Feb; 31(2):241-256. PubMed ID: 31980588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
    Chen Q; Wiesener M; Eberhardt HU; Hartmann A; Uzonyi B; Kirschfink M; Amann K; Buettner M; Goodship T; Hugo C; Skerka C; Zipfel PF
    J Clin Invest; 2014 Jan; 124(1):145-55. PubMed ID: 24334459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.
    Gale DP; de Jorge EG; Cook HT; Martinez-Barricarte R; Hadjisavvas A; McLean AG; Pusey CD; Pierides A; Kyriacou K; Athanasiou Y; Voskarides K; Deltas C; Palmer A; Frémeaux-Bacchi V; de Cordoba SR; Maxwell PH; Pickering MC
    Lancet; 2010 Sep; 376(9743):794-801. PubMed ID: 20800271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene.
    Xiao X; Ghossein C; Tortajada A; Zhang Y; Meyer N; Jones M; Borsa NG; Nester CM; Thomas CP; de Córdoba SR; Smith RJ
    Mol Immunol; 2016 Sep; 77():89-96. PubMed ID: 27490940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant.
    Vernon KA; Gale DP; de Jorge EG; McLean AG; Galliford J; Pierides A; Maxwell PH; Taube D; Pickering MC; Cook HT
    Am J Transplant; 2011 Jan; 11(1):152-5. PubMed ID: 21114651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and glomerular disease: new insights.
    Pickering M; Cook HT
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):271-7. PubMed ID: 21422921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.
    Deltas C; Gale D; Cook T; Voskarides K; Athanasiou Y; Pierides A
    Adv Exp Med Biol; 2013; 735():189-96. PubMed ID: 23402027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3 glomerulopathy: what's in a name?
    D'Agati VD; Bomback AS
    Kidney Int; 2012 Aug; 82(4):379-81. PubMed ID: 22846813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy.
    Frangou E; Varnavidou-Nicolaidou A; Petousis P; Soloukides A; Theophanous E; Savva I; Michael N; Toumasi E; Georgiou D; Stylianou G; Mean R; Anastasiadou N; Athanasiou Y; Zavros M; Kyriacou K; Deltas C; Hadjianastassiou V
    Nephrol Dial Transplant; 2019 Oct; 34(10):1780-1788. PubMed ID: 30844074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency.
    Vernon KA; Goicoechea de Jorge E; Hall AE; Fremeaux-Bacchi V; Aitman TJ; Cook HT; Hangartner R; Koziell A; Pickering MC
    Am J Kidney Dis; 2012 Jul; 60(1):121-5. PubMed ID: 22503529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement factor H related proteins (CFHRs).
    Skerka C; Chen Q; Fremeaux-Bacchi V; Roumenina LT
    Mol Immunol; 2013 Dec; 56(3):170-80. PubMed ID: 23830046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dense deposit disease and C3 glomerulopathy.
    Barbour TD; Pickering MC; Terence Cook H
    Semin Nephrol; 2013 Nov; 33(6):493-507. PubMed ID: 24161036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
    Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
    Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
    Malik TH; Gitterman DP; Lavin DP; Lomax-Browne HJ; Hiemeyer EC; Moran LB; Boroviak K; Cook HT; Gilmore AC; Mandwie M; Ahmad A; Alexander IE; Logan GJ; Marchbank KJ; Bradley A; Pickering MC
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical research advances of CFHR5 nephropathy: a recent review.
    Fei ZG; Zhen K; Zhang FJ; Liu PY; Xu HY; Chen HH
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9987-10000. PubMed ID: 37916369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.